Skip to main content

Ardy Arianpour

Celmatix has appointed Ardy Arianpour to its corporate advisory board. Most recently, Arianpour served as chief commercial officer of Pathway Genomics. He has also held senior executive roles at a number of leading personalized medicine companies including Ambry Genetics and the Cogenics division of Clinical Data.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.